mainly due to the increased in cost of sales and services of many large-scale projects which their gross margin were low due to a high market competition. In addition, In Q2–2019, there was an additional
due to the higher gross profit and the lower administrative expenses. As a result, overall net profit of the Group is increased. Analysis of revenues Q1’ 2018 Q1’ 2017 Increase (decrease) Million Baht
which posted 26% growth yoy due to more intensity treatment, epidemics and weather change in the beginning of this year as well as increasing number of beds in service. Cost of Hospital Operations Cost of
New Products สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 01 April 2022 18:49 New Product Prospectus / Filing Sales Report Shelf Approval Outstanding Domestic Debt PP Approval Equity
New Products สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 01 April 2022 19:06 New Product Prospectus / Filing Sales Report Shelf Approval Outstanding Domestic Debt PP Approval Equity
2020, National Economic and Social Development Council (NESDC) forecasted Thailand’s economy to expand by 1.5- 2.5 percent, softening from 2019 due to impacts from the coronavirus (Covid-19) outbreak
reduction. However, outstanding loss remained due to 1) sales shrinkage; 2) higher cost as a result of higher depreciation from investments in machinery; 3) higher financial costs from investments; and 4) one
%, due to the following reasons as follows; 1. Total incomes of the Company increases to 119.47 million baht equal to 67.86% against to the same period of last year mainly due to: 1.1) Revenue from Sales
. Income from medical treatments in the consolidated financial Statement went up 6.81% due to income from Chiang Mai Ram Medical Business Plc.”CMR”, a subsidiary amount Baht 3,747.64 million went up from
: Daol Securities (Thailand) Public Company Limited serves as the bondholders’ representative for the seven series of GRAND bonds as follows: GRAND257A bond due on 14 July 2025